Time-action profile of insulin glargine (HOE901) in Japanese volunteers

被引：0

|

作者：

Rave, K

Heise, T

Heinemann, L

机构：

来源：

DIABETES | 2000年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1524

引用

收藏

页码：A363 / A363

页数：1

相关论文

共 50 条

[31] Time-action profile of a new pulmonary insulin applied with a metered-dose inhaler
Kapitza, C
Heise, T
McGovern, M
Cefali, E
Buchwald, A
Heinemann, L
Hompesch, M
DIABETES, 2003, 52 : A105 - A105
[32] Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens
Rosenstock, J
Park, G
Zimmerman, J
DIABETES CARE, 2000, 23 (08) : 1137 - 1142
[33] Basal insulin therapy in type 2 diabetes - 28-week comparison of insulin glargine (HOE 901) and NPH insulin
Rosenstock, J
Schwartz, SL
Clark, CM
Park, GD
Donley, DW
Edwards, MB
DIABETES CARE, 2001, 24 (04) : 631 - 636
[34] The variability and time-action profile of inhaled Technosphere/Insulin compares favorably to that of subcutaneous human regular insulin
Boss, AH
Heise, T
Rave, K
Cheatham, WW
DIABETES, 2005, 54 : A88 - A88
[35] Time-action profile for intravenously infused insulin aspart and insulin lispro in type 1 diabetic subjects
Hamilton-Wessler, M
Buchanan, T
Hathout, E
Kolaczynski, J
Bajwa, R
Nakao, S
Ross, E
Bergman, RN
DIABETES, 2002, 51 : A99 - A99
[36] Time-action profile of insulin lispro and regular insulin in patients with type 1 diabetes and diabetic nephropathy
Rave, R
Sawicki, PT
Heise, T
Heinemann, L
DIABETOLOGIA, 2000, 43 : A197 - A197
[37] Comparative clinical trial of a new long-acting insulin (HOE901) vs. protamine insulin demonstrates less nocturnal hypoglycaemia
Matthews, DR
Pfeiffer, C
DIABETES, 1998, 47 : A101 - A101
[38] Proportion and clinical profile of type 1 diabetes patients with a clinical time-action of insulin glargine U100 shorter than 24 hours
Albareda, Merce
Lara, Merce
Martin-Baranera, Montserrat
Barnes, Raquel
Vila, Lluis
PRACTICAL DIABETES, 2020, 37 (03) : 87 - +
[39] Inhaled Technosphere/Insulin: Favourable time-action profile and low variability in comparison to subcutaneous human regular insulin
Cheatham, WW
Rave, K
Boss, AH
Heise, T
DIABETOLOGIA, 2005, 48 : A30 - A30
[40] A new long-acting insulin (HOE901) demonstrates less nocturnal hypoglycaemia when compared with protamine insulin in a clinical trial.
Matthews, DR
Pfeiffer, C
DIABETOLOGIA, 1998, 41 : A245 - A245

← 1 2 3 4 5 →